Plasma biomarkers in CJD reveal multisystem involvement, with neuronal injury markers showing strong discriminative performance and vascular proteins indicating blood–brain barrier dysfunction. In asymptomatic PRNP mutation carriers, biomarker changes are minimal and emerge mainly near disease onset ABSTRACT Background Plasma markers of neuronal injury
Zhong‐Yun Chen +11 more
wiley +1 more source
Redox mechanisms and their pathological role in prion diseases: The road to ruin. [PDF]
Spiers JG, Chen HC, Steinert JR.
europepmc +1 more source
TDP‐43Q331K mice exhibit altered proliferative dynamics in oligodendrocytes and their precursors. Oligodendroglial cell death is evident in TDP‐43Q331K mice. TDP‐43Q331K mice display altered myelin reflectance and pathology in the spinal cord. ABSTRACT Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by the ...
Katherine N. Lewis +8 more
wiley +1 more source
Collaborative strategies for wildlife health: case studies from the Canadian North
The integration of Indigenous perspectives with a One Health approach enables culturally relevant and sustainable zoonotic disease management and surveillance, as demonstrated through 4 case studies that highlight how empowering communities and facilitating inclusive, respectful, and collaborative governance across diverse sectors and knowledge systems
Cody J. Malone +8 more
wiley +1 more source
Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseases. [PDF]
Pulido RS +10 more
europepmc +1 more source
Role of CD40 in prion disease and the immune response to recombinant PrP
Richard Rubenstein +3 more
openalex +2 more sources
Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
Abstract INTRODUCTION The locus coeruleus (LC) is a small nucleus located deep within the brainstem, serving as the brain's main source of noradrenergic neurons. Through its extensive projections, it plays a critical role in regulating cognitive processes and arousal.
Anaëlle Bain +5 more
wiley +1 more source
Therapeutic perspectives for prion diseases in humans and animals. [PDF]
Benavente R, Morales R.
europepmc +1 more source
Palliative Care Resource Utilization in Patients With Prion Disease
Roaa Zayat +4 more
openalex +2 more sources
A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases [PDF]
Thibaut Imberdis +8 more
openalex +1 more source

